Table 2. Characteristics of subjects by baseline CD4+ T-lymphocytes (CD4) levels (N=381).
Baseline CD4 count category(cells/mm3)a
|
P value | ||||
---|---|---|---|---|---|
1st quartile | 2nd quartile | 3rd quartile | 4th quartile | ||
≤30 | 31–86 | 87–173 | ≥174 | ||
Characteristics | n = 100 | n = 91 | n = 95 | n = 95 | |
Age (years), mean ± SD | 38.0 ± 10.8 | 39.9 ± 11.7 | 38.9 ± 11.0 | 39.0 ± 11.0 | P = 0.776 |
Gender | |||||
• Male | 69 (69%) | 62 (68%) | 61 (64%) | 61 (64%) | P = 0.841 |
• Female | 31 (31%) | 29 (32%) | 34 (36%) | 34 (36%) | |
Mode of transmission | |||||
• Blood transfusion | 1 (1%) | 4 (5%) | 0 (0%) | 0 (0%) | P = 0.051 |
• Injectable drug use | 1 (1%) | 7 (8%) | 7 (7%) | 6 (6%) | |
• Homosexual | 2 (2%) | 2 (2%) | 5 (5%) | 2 (2%) | |
• Heterosexual | 79 (79%) | 62 (67%) | 70 (74%) | 78 (82%) | |
• Unknown | 17 (17%) | 16 (18%) | 13 (14%) | 9 (10%) | |
Time between western blot test positive and ART initiation (months)b | 1.2 (0.8–2.0) | 1.6 (0.9–6.0) | 6.1 (1.4–22.0) | 9.6 (1.6–22.4) | P < 0.001 |
Symptom at baseline | |||||
• Persistent diarrhoea | 12 (12%) | 14 (15%) | 4 (4%) | 8 (8%) | P = 0.066 |
• Persistent fever | 50 (50%) | 40 (44%) | 23 (24%) | 23 (24%) | P < 0.001 |
The figures indicate the number of cases, unless otherwise indicated.
Based on the 25, 50 (median), and 75 percentile values of the baseline CD4 counts, the 381 subjects were divided into 4 groups.
Median, (Interquartile range: 1st–3rd Quartiles).